Business ❯ Healthcare

Pharmaceuticals

Drug Development Clinical Trials Market Competition Weight Loss Drugs Drug Pricing Biotechnology Manufacturing Oncology Acquisitions Market Trends

Sarepta Reports Early siRNA Results Showing Muscle Targeting as Shares Rise

The readouts offer early validation for a muscle‑targeted RNA platform Sarepta licensed from Arrowhead.

Merck to Acquire Terns Pharmaceuticals for $6.7 Billion in Cash

CVS, FTC Reach Proposed Settlement Over Insulin Pricing

Sanofi Licenses Kali’s Tri-Specific Autoimmune Antibody KT501 in Deal Worth Up to $1.23 Billion

Plaintiff Firms Intensify Biotech Securities Suits as Key Deadlines Near for Nektar, uniQure and REGENXBIO

Karyopharm Raises $30 Million in RA Capital Private Placement

AbbVie and Bristol Myers Defy Their Sector With Rising Dividends Fueled by New Drugs

Law Firms Seek Soleno Investors Ahead of May 5 Lead‑Plaintiff Deadline

Novartis Strikes $2 Billion Deal for Mutant-Selective PI3Kα Cancer Drug SNV4818

Biofrontera Reports Record 2025 Revenue of $41.7 Million and Best-Ever Q4 at $17.1 Million

Taysha Advances Rett Gene Therapy Program With Pivotal Dosing, FDA Alignment and Q2 Data Timeline

Eton Pharma Launches FDA-Approved Desmota as Revenue and Margins Jump

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

Law Firms Urge Nektar Investors to Seek Lead Role in Securities Suit Over REZOLVE-AA Trial

Analyses Find Limited Savings as TrumpRx Reaches 54 Drugs

Collegium to Acquire AZSTARYS for $650 Million, Adding Second ADHD Medicine

Roche Expands NVIDIA Partnership, Building Pharma’s Largest Hybrid‑Cloud AI Factory

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety and Launch Claims

HSBC Cuts Eli Lilly to Reduce, Lowers Target to $850 on GLP-1 Reset

Lifecore Posts Higher Q4 Sales and Margin, Guides 2026 Revenue Down on Customer Timing